Safety, tolerability and pharmacokinetics of TAS-108, a novel anti-oestrogen, in healthy post-menopausal Japanese women: a phase I single oral dose study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples